6 employees
Regulaxis is focused in research, development and licensing of human innovative synthetic molecules for high unmet medical needs
2013
$2.4M
from 1 investors over 1 rounds
Regulaxis SAS raised $2.4M on June 1, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)